Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers

被引:27
作者
Berlin, I
SpreuxVaroquaux, O
Said, S
Launay, JM
机构
[1] CTR HOSP VERSAILLES, PHARMACOL & TOXICOL CTR, DEPT BIOCHEM, LE CHESNAY, FRANCE
[2] HOP LARIBOISIERE, DEPT BIOCHEM, F-75475 PARIS, FRANCE
关键词
dependent smokers; past history of depression; monoamine oxidases; withdrawal symptoms;
D O I
10.1016/S0376-8716(97)01338-0
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Past history of major depression is more common in smokers than in non-smokers. We have shown in a previous study that lifetime prevalence of major depression is higher in dependent smokers and they have lower monoamine oxidase-A and -B activities than non-smokers. Because several studies have found an association between MAO-B activity and depression we analysed data of these smokers to assess:whether past history of major depression is associated with reduced monoamine oxidase activities (A and B) or not. Further, we tried to characterize smokers with past history of major depression and its effect on withdrawal symptoms. The data of 88 dependent smokers (Fagerstrom Tolerance Questionnaire score greater than or equal to 6 and smoking greater than or equal to 20 cigarettes/day) who participated in a smoking cessation study were analysed. Smokers with past history of major depression but without current illness did not differ in demographic and smoking characteristics from smokers without past history of major depression. Smokers with past history of major depression were mainly women and had lower body mass index. Adjusted for gender and body mass index dependent smokers with or without past history of depression had similar MAO-A and MAO-B activities but smokers with past history of major depression had significantly lower resting plasma norepinephrine levels. Smokers with past history of depression had not significantly higher ratings for depression (Montgomery-Asberg Depression Rating Scales) and anxiety (Hamilton Anxiety Scales) and smoking cessation did not exacerbate these ratings (assessed up to 3 months) and none had depressive episode during the postcessation period up to one year. Past history of depression was associated with higher scores on 'expressed sadness' and 'depressive mood'. Abstinent smokers with past history of depression had significantly higher ratings in one of the seven ratings of a 6 months period for craving (day 28), anxiety (day 7) and total withdrawal symptom score (day 7) when compared to those who had no past history of major depression. It is concluded that (i) past history of major depression is more frequent in female smokers (ii) smokers with past history of depression may have more intense withdrawal symptoms (craving and anxiety) at some time after cessation; and (iii) past history of depression does not affect monoamine oxidase activities, therefore, reduced monoamine oxidase activities found in previous studies are possibly characteristic features of smoking. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 38 条
[1]   DEPRESSION AND THE DYNAMICS OF SMOKING - A NATIONAL PERSPECTIVE [J].
ANDA, RF ;
WILLIAMSON, DF ;
ESCOBEDO, LG ;
MAST, EE ;
GIOVINO, GA ;
REMINGTON, PL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (12) :1541-1545
[2]   ALTERATIONS IN BETA-ADRENERGIC SENSITIVITY AND PLATELET ALPHA-2-ADRENOCEPTORS IN OBESE WOMEN - EFFECT OF EXERCISE AND CALORIC RESTRICTION [J].
BERLIN, I ;
BERLAN, M ;
CRESPOLAUMONNIER, B ;
LANDAULT, C ;
PAYAN, C ;
PUECH, AJ ;
TURPIN, G .
CLINICAL SCIENCE, 1990, 78 (01) :81-87
[3]   MONOAMINE-OXIDASE-A AND MONOAMINE-OXIDASE-B ACTIVITIES IN HEAVY SMOKERS [J].
BERLIN, I ;
SAID, S ;
SPREUXVAROQUAUX, O ;
OLIVARES, R ;
LAUNAY, JM ;
PUECH, AJ .
BIOLOGICAL PSYCHIATRY, 1995, 38 (11) :756-761
[4]   A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS [J].
BERLIN, I ;
SAID, S ;
SPREUXVAROQUAUX, O ;
LAUNAY, JM ;
OLIVARES, R ;
MILLET, V ;
LECRUBIER, Y ;
PUECH, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) :444-452
[5]   PRESSOR FACTORS AND CARDIOVASCULAR PRESSOR RESPONSIVENESS IN LEAN AND OVERWEIGHT NORMAL OR HYPERTENSIVE SUBJECTS [J].
BOEHRINGER, K ;
BERETTAPICCOLI, C ;
WEIDMANN, P ;
MEIER, A ;
ZIEGLER, W .
HYPERTENSION, 1982, 4 (05) :697-702
[6]  
BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P1069
[7]   DEPRESSION AND MONOAMINE-OXIDASE [J].
COPER, H ;
FAHNDRICH, E ;
GEBERT, A ;
HELMCHEN, H ;
HONECKER, H ;
MULLEROERLINGHAUSEN, B ;
PIETZCKER, A .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1979, 3 (5-6) :441-463
[8]   DEPRESSION AND DEPRESSIVE SYMPTOMS IN SMOKING CESSATION [J].
COVEY, LS ;
GLASSMAN, AH ;
STETNER, F .
COMPREHENSIVE PSYCHIATRY, 1990, 31 (04) :350-354
[9]  
DALACK GW, 1995, AM J PSYCHIAT, V152, P398
[10]  
EDWARDS DJ, 1978, ARCH GEN PSYCHIAT, V35, P1443